Targeting Wnt signaling with Signalomics in primary breast cancer and gynecological pathologies

preprint OA: closed CC-BY-4.0
AI-generated summary by qwen3.7-flash, 2026-09-19

Signalomics analysis of primary breast and gynecological samples, including endometriosis, revealed Wnt signaling levels correlate with disease progression and that pharmacological inhibition suppresses cell proliferation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-09-19 · read from full text

This preprint investigates the utility of Signalomics, a method for assessing oncogenic pathway activation, in primary breast cancer and various gynecological pathologies. The researchers analyzed surgical samples from patients with ovarian and endometrial cancers as well as endometriosis to measure basal and stimulated Wnt signaling levels. They found that these signaling levels correlated with disease progression and demonstrated that pharmacological inhibition of the Wnt pathway suppressed cell proliferation in many of the tested primary samples. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Breast and gynecological pathologies, such as endometriosis and cancers, rely on aberrant activation of pro-proliferative pathways like Wnt signaling. In addition to multiple omics techniques utilized to identify drivers and targetable vulnerabilities in these diseases, Signalomics has recently emerged as a new tool to rapidly assess the levels of activation of oncogenic signaling pathways in primary cells. Here we demonstrate the power of Signalomics when applied to patients with breast, ovarian, and endometrial cancers, as well as endometriosis. Assessing basal and stimulated levels of Wnt signaling in patients’ surgical samples, we find these levels to correlate with the disease progression. We further show that pharmacological inhibition of the Wnt pathway in many of these primary samples suppresses cell proliferation, offering means for patient stratification prior to eventual targeted treatment. Altogether, our study is the first example of Signalomics applications in daily clinical settings, offering insights into disease mechanisms and personalized treatment.
Full text 17,859 characters · extracted from preprint-html · click to expand
Targeting Wnt signaling with Signalomics in primary breast cancer and gynecological pathologies | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Help Center Sign In Submit a Preprint Cite Share Download PDF Article Targeting Wnt signaling with Signalomics in primary breast cancer and gynecological pathologies Tatiana V. Denisenko, Anna E. Ivanova, Alexey Koval, Denis N. Silachev, and 9 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-10900657/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Breast and gynecological pathologies, such as endometriosis and cancers, rely on aberrant activation of pro-proliferative pathways like Wnt signaling. In addition to multiple omics techniques utilized to identify drivers and targetable vulnerabilities in these diseases, Signalomics has recently emerged as a new tool to rapidly assess the levels of activation of oncogenic signaling pathways in primary cells. Here we demonstrate the power of Signalomics when applied to patients with breast, ovarian, and endometrial cancers, as well as endometriosis. Assessing basal and stimulated levels of Wnt signaling in patients’ surgical samples, we find these levels to correlate with the disease progression. We further show that pharmacological inhibition of the Wnt pathway in many of these primary samples suppresses cell proliferation, offering means for patient stratification prior to eventual targeted treatment. Altogether, our study is the first example of Signalomics applications in daily clinical settings, offering insights into disease mechanisms and personalized treatment. Health sciences/Biomarkers Biological sciences/Cancer Biological sciences/Computational biology and bioinformatics Health sciences/Oncology Full Text Additional Declarations Competing interest reported. V.L.K. is a co-founder and holds equity shares in Wynveris SA, a company based in Geneva, Switzerland. V.L.K. is a co-inventor on a patent application "New Frizzled receptors inhibitors and uses thereof", which was filed by the University of Geneva. Supplementary Files SupplementaryFig.S1.pdf SupplementaryFig.S2May11.pdf SupplementaryTableS1.docx SupplementaryTableS2.docx SupplementaryTableS3.docx SupplementaryTableS4Sept2.docx Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About In Review Editorial Policies Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-10900657","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":716619780,"identity":"290cd6b3-d5b1-4777-989f-5d432bd26340","order_by":0,"name":"Tatiana V. Denisenko","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Tatiana","middleName":"V.","lastName":"Denisenko","suffix":""},{"id":716619781,"identity":"68019a42-7600-48bc-8b8e-8e42ffce297e","order_by":1,"name":"Anna E. Ivanova","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Anna","middleName":"E.","lastName":"Ivanova","suffix":""},{"id":716619782,"identity":"c4a02d05-faab-487f-bda3-160ebf3d09e3","order_by":2,"name":"Alexey Koval","email":"","orcid":"","institution":"University of Geneva","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Alexey","middleName":"","lastName":"Koval","suffix":""},{"id":716619783,"identity":"3e38911f-f456-489f-8f84-819aa4e2b99f","order_by":3,"name":"Denis N. Silachev","email":"","orcid":"","institution":"University of Geneva","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Denis","middleName":"N.","lastName":"Silachev","suffix":""},{"id":716619784,"identity":"553ca32e-e862-405e-ad2b-de4d4fa7433a","order_by":4,"name":"Vlada V. Kometova","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Vlada","middleName":"V.","lastName":"Kometova","suffix":""},{"id":716619785,"identity":"524c232d-22dc-49d4-9d74-b32c962e1a6c","order_by":5,"name":"Madina R. Dumanovskaya","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Madina","middleName":"R.","lastName":"Dumanovskaya","suffix":""},{"id":716619786,"identity":"2e655e52-dfb3-45f3-85a3-65ae02273517","order_by":6,"name":"Alexandra V. Asaturova","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Alexandra","middleName":"V.","lastName":"Asaturova","suffix":""},{"id":716619787,"identity":"296367c6-8c62-4de0-94c6-5e1e633dcdc6","order_by":7,"name":"Gyuzyal I. Tabeeva","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Gyuzyal","middleName":"I.","lastName":"Tabeeva","suffix":""},{"id":716619788,"identity":"06d8f93e-3f8b-450b-91e5-63a8d838942e","order_by":8,"name":"Antonina A. Smetnik","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Antonina","middleName":"A.","lastName":"Smetnik","suffix":""},{"id":716619789,"identity":"1228a31c-5372-4253-8a82-401b387255d5","order_by":9,"name":"Valery V. Rodionov","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Valery","middleName":"V.","lastName":"Rodionov","suffix":""},{"id":716619790,"identity":"37a03fd8-b659-4cfd-8e0b-7c7145e521d1","order_by":10,"name":"Lev A. Ashrafyan","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Lev","middleName":"A.","lastName":"Ashrafyan","suffix":""},{"id":716619791,"identity":"2a7fdbf4-db55-4c53-b269-56914ce8a4ab","order_by":11,"name":"Gennadiy T. Sukhikh","email":"","orcid":"","institution":"National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Gennadiy","middleName":"T.","lastName":"Sukhikh","suffix":""},{"id":716619792,"identity":"b3079cfe-c8db-42d5-ac18-a24600cb74fb","order_by":12,"name":"Vladimir L. Katanaev","email":"data:image/png;base64,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","orcid":"","institution":"University of Geneva","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Vladimir","middleName":"L.","lastName":"Katanaev","suffix":""}],"badges":[],"createdAt":"2026-09-02 05:08:48","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-10900657/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-10900657/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":120297922,"identity":"6646ab0d-484f-486d-ae6d-96bd0576e312","added_by":"auto","created_at":"2026-09-16 09:12:47","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":312623,"visible":true,"origin":"","legend":"","description":"","filename":"DenisenkoetalSept2.pdf","url":"https://assets-eu.researchsquare.com/files/rs-10900657/v1_covered_95659bee-43c6-457a-9f96-134d6d27e29f.pdf"},{"id":120295460,"identity":"1e1ca929-3ef8-456f-bf45-eca96c32587a","added_by":"auto","created_at":"2026-09-16 08:55:35","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":4411812,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryFig.S1.pdf","url":"https://assets-eu.researchsquare.com/files/rs-10900657/v1/649d9e6e83941d5019f5f381.pdf"},{"id":120295587,"identity":"0c70fe68-c195-40da-b574-0d8cc28507fa","added_by":"auto","created_at":"2026-09-16 08:56:02","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":1168739,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryFig.S2May11.pdf","url":"https://assets-eu.researchsquare.com/files/rs-10900657/v1/61dc0d538caaaee31345fd8b.pdf"},{"id":120295521,"identity":"599485f8-dd7d-4d35-9d16-e13bf59e7a35","added_by":"auto","created_at":"2026-09-16 08:55:48","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":20756,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTableS1.docx","url":"https://assets-eu.researchsquare.com/files/rs-10900657/v1/5be9b5e32b4191f57ebb6a80.docx"},{"id":120295497,"identity":"31050d75-785b-465f-ad75-6afd2fa4c3b4","added_by":"auto","created_at":"2026-09-16 08:55:45","extension":"docx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":17952,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTableS2.docx","url":"https://assets-eu.researchsquare.com/files/rs-10900657/v1/b2e91b713facb53f864d8870.docx"},{"id":120295629,"identity":"7621f77f-ecc3-4773-9aa5-2d60a8496962","added_by":"auto","created_at":"2026-09-16 08:56:09","extension":"docx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":20947,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTableS3.docx","url":"https://assets-eu.researchsquare.com/files/rs-10900657/v1/a04628fdf827616970687343.docx"},{"id":120295494,"identity":"61239fef-4b17-4ae2-b001-1d83ebde3b28","added_by":"auto","created_at":"2026-09-16 08:55:41","extension":"docx","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":21529,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTableS4Sept2.docx","url":"https://assets-eu.researchsquare.com/files/rs-10900657/v1/cdb1fa2706638dd090fd9c3d.docx"}],"financialInterests":"Competing interest reported. V.L.K. is a co-founder and holds equity shares in Wynveris SA, a company based in Geneva, Switzerland. V.L.K. is a co-inventor on a patent application \"New Frizzled receptors inhibitors and uses thereof\", which was filed by the University of Geneva.","formattedTitle":"Targeting Wnt signaling with Signalomics in primary breast cancer and gynecological pathologies","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-10900657/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-10900657/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Breast and gynecological pathologies, such as endometriosis and cancers, rely on aberrant activation of pro-proliferative pathways like Wnt signaling. In addition to multiple omics techniques utilized to identify drivers and targetable vulnerabilities in these diseases, Signalomics has recently emerged as a new tool to rapidly assess the levels of activation of oncogenic signaling pathways in primary cells. Here we demonstrate the power of Signalomics when applied to patients with breast, ovarian, and endometrial cancers, as well as endometriosis. Assessing basal and stimulated levels of Wnt signaling in patients’ surgical samples, we find these levels to correlate with the disease progression. We further show that pharmacological inhibition of the Wnt pathway in many of these primary samples suppresses cell proliferation, offering means for patient stratification prior to eventual targeted treatment. Altogether, our study is the first example of Signalomics applications in daily clinical settings, offering insights into disease mechanisms and personalized treatment.","manuscriptTitle":"Targeting Wnt signaling with Signalomics in primary breast cancer and gynecological pathologies","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-09-16 08:50:41","doi":"10.21203/rs.3.rs-10900657/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"2f8d9858-756b-4716-a5d6-9a25888f02d6","owner":[],"postedDate":"September 16th, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":76015086,"name":"Health sciences/Biomarkers"},{"id":76015087,"name":"Biological sciences/Cancer"},{"id":76015088,"name":"Biological sciences/Computational biology and bioinformatics"},{"id":76015089,"name":"Health sciences/Oncology"}],"tags":[],"updatedAt":"2026-09-16T08:50:41+00:00","versionOfRecord":[],"versionCreatedAt":"2026-09-16 08:50:41","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-10900657","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-10900657","identity":"rs-10900657","version":["v1"]},"buildId":"pf3fE39SIOqb-0xH_OWvX","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-21T07:13:24.865968+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC-BY-4.0